News

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...
This is the first time such results have been achieved in both children and adult patients born with a specific type of ...
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...
Preclinical data support a novel combination of MB-101 (IL13Ra2-targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus) to optimize clinical results FDA previously granted Orphan Drug ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...
Text BEACH to 515151 for your chance to win two nights in an oceanfront room at Surf & Sand Laguna Beach, plus a $500 resort ...
More information: Gabriel I. Small et al, The mechanism for GTP-mediated RNA capping by the SARS-CoV-2 NiRAN domain remains unresolved, Cell (2025). DOI: 10.1016/j.cell.2025.05.044 ...
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces it has engaged Enclave Capital LLC ( ...
Salarius also announces continued progress in its planned merger with Decoy Therapeutics Inc. (Decoy). Under the definitive agreement announced on January 13, 2025, Decoy will merge with a wholly ...